NASDAQ:EYEG AB Corporate Bond ETF (EYEG) Price, Holdings, & News → Beta testers blew this thing up (From Prosper Trading Academy) (Ad) Free EYEG Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$35.54▼$35.5450-Day Range$1.59▼$2.2552-Week Range$1.44▼$8.18Volume9 shsAverage Volume935,975 shsMarket Capitalization$24.88 millionAssets Under ManagementN/ADividend Yield1.97%Net Expense Ratio0.30% Stock AnalysisStock AnalysisDividendHeadlinesTrendsStock AnalysisDividendHeadlinesTrends Get AB Corporate Bond ETF alerts: Email Address About AB Corporate Bond ETF (NASDAQ:EYEG)EyeGate Pharmaceuticals, Inc. is a clinical stage specialty pharmaceutical company, which engages in the development and commercialization of products for treating diseases and disorders of the eye. Its pipeline includes MoxiGel and Ocular Bandage Gel. The company was founded in 1998 and is headquartered in Waltham, MA.Read More Ad Behind the MarketsBigger Than NVIDIA?With NVIDIA flying high, everyone is looking for the next breakout stock. But right now... There's only ONE stock you should be watching.Get the full story here >>> EYEG ETF News HeadlinesMay 2, 2024 | markets.businessinsider.comEQS-News: NEON EQUITY AG: Prospectus approval for 10% Corporate Bond 2024/2029April 22, 2024 | msn.comInvesco International Corporate Bond ETF declares monthly distribution of $0.0549April 5, 2024 | finance.yahoo.comAB Core Bond ETF (EYEG)April 1, 2024 | msn.comiShares ESG Aware USD Corporate Bond ETF declares monthly distribution of $0.0781March 26, 2024 | markets.businessinsider.comBHG Financial Completes First Consumer-Only ABS Transaction, Closes Over $273M in ABS NotesMarch 19, 2024 | msn.comInvesco BulletShares 2029 Corporate Bond ETF declares monthly distribution of $0.0619March 18, 2024 | msn.comAMC Entertainment Tops The List Of High-Yielding Corporate Bonds — A Look At Yields As Bond Appetites GrowFebruary 25, 2024 | msn.comCompare with VictoryShares Corporate Bond ETF (UCRD)See More Headlines Receive EYEG Stock News and Ratings via Email Sign-up to receive the latest news and ratings for AB Corporate Bond ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address Fund Details IssuerAllianceBernstein Fund NameAB Corporate Bond ETF Tax ClassificationRegulated Investment Company Stock ExchangeNASDAQCurrent SymbolNASDAQ:EYEG Inception Date12/13/2023 Fund ManagerTimothy Kurpis, Bernd Wuebben Webwww.eyegatepharma.com Phone(781) 788-8869Fund Focus Asset ClassFixed Income BenchmarkN/A CategoryCorporate FocusInvestment Grade Development LevelBlended Development RegionGlobal Number of Holdings391 Fund Statistics Assets Under Management$0.00 Average Daily Volume$0.00 Discount/Premium0.00% Administrator, Advisor and Custodian AdministratorState Street Bank and Trust Company AdvisorAllianceBernstein L.P. CustodianState Street Bank and Trust Company DistributorForeside Fund Services, LLC Transfer AgentState Street Bank and Trust Company TrusteeN/A Lead Market MakerJane Street Miscellaneous Outstanding Shares700,000Beta0.16 Creation Unit50,000 Creation Fee$250.00 10 "Recession Proof" Stocks That Will Thrive in Any MarketWhich stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.Get This Free Report Ad Behind the MarketsBigger Than NVIDIA?With NVIDIA flying high, everyone is looking for the next breakout stock. But right now... There's only ONE stock you should be watching.Get the full story here >>> AB Corporate Bond ETF ExpensesTypeEYEGInvestment Grade ETFsFixed Income ETFsNASDAQ ETFsAll ETFsManagement Fee0.30%0.22%0.32%0.47%0.51%Other Expenses0.00%0.13%0.26%0.39%0.54%Total Expense0.30%0.25%0.40%0.60%0.71%Fee Waiver0.00%-0.15%-0.25%-0.32%-0.60%Net Expense0.30%0.22%0.35%0.54%0.58% AB Corporate Bond ETF (EYEG)Full Holdings Details Key ExecutivesBrian Matthew StremPresident, Chief Executive Officer & DirectorSarah M. RomanoChief Financial & Accounting OfficerLisa BrandanoVice President-Clinical OperationsFranz ObermayrExecutive Vice President-Clinical DevelopmentBrenda K. MannVice President-Research & DevelopmentSimilar ETFsJaguar HealthNASDAQ:JAGXTetraphase PharmaceuticalsNASDAQ:TTPHFidelity Low Duration Bond ETFNASDAQ:FLDBStrive Enhanced Income Short Maturity ETFNYSE:BUXXWisdomTree Bianco Total Return FundNASDAQ:WTBN EYEG ETF - Frequently Asked Questions How were AB Corporate Bond ETF's earnings last quarter? AB Corporate Bond ETF (NASDAQ:EYEG) announced its quarterly earnings data on Thursday, August, 12th. The specialty pharmaceutical company reported ($0.35) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.42) by $0.07. How often does AB Corporate Bond ETF pay dividends? What is the dividend yield for AB Corporate Bond ETF? AB Corporate Bond ETF announced a monthly dividend on Friday, May 31st. Shareholders of record on Monday, June 3rd will be given a dividend of $0.1539 per share on Thursday, June 6th. This represents a $1.85 annualized dividend and a dividend yield of 5.20%. The ex-dividend date of this dividend is Monday, June 3rd. Read our dividend analysis for EYEG. What does EYEG invest in? AB Corporate Bond ETF is a fixed income fund issued by AllianceBernstein. EYEG focuses on investment grade investments. What is the management fee for AB Corporate Bond ETF? AB Corporate Bond ETF's management fee is 0.30% and has no other recorded expenses or fee waivers. The net expense ratio for EYEG is 0.30%. What other stocks do shareholders of AB Corporate Bond ETF own? Based on aggregate information from My MarketBeat watchlists, some companies that other AB Corporate Bond ETF investors own include Bausch Health Companies (BHC), MannKind (MNKD), Sorrento Therapeutics (SRNE), Idera Pharmaceuticals (IDRA), Celldex Therapeutics (CLDX), Novavax (NVAX), SCYNEXIS (SCYX), Trevena (TRVN), Exelixis (EXEL) and Gilead Sciences (GILD). When did AB Corporate Bond ETF IPO? AB Corporate Bond ETF (EYEG) raised $5 million in an initial public offering (IPO) on Friday, February 13th 2015. The company issued 800,000 shares at a price of $6.00 per share. Aegis Capital Corp and Chardan Capital Markets acted as the underwriters for the IPO. This page (NASDAQ:EYEG) was last updated on 6/18/2024 by MarketBeat.com Staff From Our PartnersBigger Than NVIDIA?With NVIDIA flying high, everyone is looking for the next breakout stock. But right now... There's only ...Behind the Markets | SponsoredBeta testers blew this thing upThis AI trading tool is probably unlike anything you've ever seen before… It scans the entire market and fi...Prosper Trading Academy | SponsoredRadical change coming — do this NOW to protect yourselfI recently uncovered a way the government could use the next crisis as a pretext to gain more control … and ra...Weiss Ratings | SponsoredUnexpected twist to Trump’s trialUnexpected Twist to Trump's Trial Most folks sense there's more to the Trump trial than meets the eye. B...Stansberry Research | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredThe #1 Crypto That You Don’t Own… YetThere’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay a...Crypto 101 Media | SponsoredElon Musk: THIS will be bigger than TeslaIf you missed out on crypto, this could be your second chance. The AI “wealth window” is opening now, but you ...Paradigm Press | SponsoredMissed NVDA? Buy this AI stock NOWAfter Nvidia's record-breaking earnings surge, Wall Street is now selling the stock at the fastest pace in sev...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AB Corporate Bond ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share AB Corporate Bond ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.